The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and …

VG Athyros, TK Alexandrides, H Bilianou… - Metabolism, 2017 - Elsevier
Non-alcoholic fatty liver disease (NAFLD), the most common liver disease, is characterized
by accumulation of fat (> 5% of the liver tissue), in the absence of alcohol abuse or other …

[HTML][HTML] Cardiovascular dysfunction in patients with liver cirrhosis

G Fede, G Privitera, T Tomaselli… - … Publication of the …, 2015 - ncbi.nlm.nih.gov
Hyperdynamic syndrome is a well-known clinical condition found in patients with cirrhosis
and portal hypertension, characterized by increased heart rate and cardiac output, and …

The role of statins in the management of nonalcoholic fatty liver disease

M Doumas, K Imprialos… - Current …, 2018 - ingentaconnect.com
Background: Non-alcoholic fatty liver disease (NAFLD) and its advanced form non-alcoholic
steatohepatitis (NASH) are the most common causes of elevated liver enzymes in the …

Diagnóstico de esteatosis hepática por métodos clínicos, bioquímicos y por imágenes

M Graffigna, N Catoira, J Soutelo… - Revista argentina de …, 2017 - SciELO Argentina
ENDOCRINOLOGÍA Y METABOLISMO Page 1 rev argent endocrinol metab. 2017;54(1):37–46
www.elsevier.es/raem REVISTA ARGENTINA DE ENDOCRINOLOGÍA Y METABOLISMO …

The co-existence of NASH and chronic kidney disease boosts cardiovascular risk: are there any common therapeutic options?

M Papademetriou, VG Athyros… - Current vascular …, 2018 - ingentaconnect.com
Non-alcoholic fatty liver disease (NAFLD) is becoming the most common chronic liver
disease. NAFLD may evolve to non-alcoholic steatohepatitis (NASH), which is causally …

Acute coronary syndromes and nonalcoholic fatty liver disease:“Un Affaire de Coeur”

A Ismaiel, SL Popa… - Canadian Journal of …, 2020 - Wiley Online Library
Background and Aims. Both nonalcoholic fatty liver disease (NAFLD) and ischemic heart
disease have common pathogenic links. Evidence for the association of NAFLD with acute …

Hepatic insulin resistance in NAFLD: relationship with markers of atherosclerosis and metabolic syndrome components

G Privitera, L Spadaro, C Alagona, S Calanna, S Piro… - Acta …, 2016 - Springer
Aims Fat accumulation in the liver and in the muscle results in hepatic and muscle insulin
resistance and has been associated with increased cardiovascular risk. It is unclear whether …

[PDF][PDF] Alcoholic fatty liver disease elevates estimated coronary heart disease risk to levels comparable with those of nonalcoholic fatty liver disease in the Korean …

HJ Kim, JH Kim, WH Choe… - Clinical and …, 2014 - synapse.koreamed.org
Background/Aims: A close relationship has been established between nonalcoholic fatty
liver disease (NAFLD) and an elevated risk of coronary heart disease (CHD), but little is …

Recent news on statins for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis

VG Athyros, N Katsiki, M Doumas - Current Vascular …, 2018 - ingentaconnect.com
Non-alcoholic fatty liver disease (NAFLD), the most common liver disease and the second
commonest disease after hypertension, occurs when there is an accumulation of fat (> 5%) …

Helicobacter Pylori infection and non-alcoholic fatty liver disease. Is there a relationship?

NR Mostafa, AAM Ali… - Healthcare in Low …, 2023 - pagepressjournals.org
The most prevalent infection that causes chronic gastritis, gastric ulcers, and gastric cancer
is Helicobacter pylori infection. Recent research has implicated H. pylori in the pathogenesis …